The Necessity of Using Heparin in the UltraTag RBC Kit When Tagging Blood for a Nuclear Medicine Study

Area of Science:

• Nuclear Medicine
• Hematology
• Biomedical Imaging

Background:

• Nuclear medicine studies utilize radiolabeled red blood cells (RBCs) for diagnostic imaging.
• Preparation of RBC kits, such as the UltraTag RBC kit, involves specific protocols to ensure sample integrity.
• The potential for blood clotting and platelet clumping during sample preparation can impact study accuracy.

Purpose of the Study:

• To evaluate the necessity of using heparin in conjunction with the UltraTag RBC kit.
• To determine if heparin is required to prevent clotting and platelet clumping in nuclear medicine studies.
• To assess the anticoagulant efficacy of the UltraTag RBC kit's components.

Main Methods:

• Samples were divided into nonheparinized and heparinized groups (n=15 each).
• Blood was added to UltraTag RBC kits, and controls were run with and without heparin.
• Macroscopic clotting (wooden applicator stick method) and microscopic platelet clumping (blood smear evaluation) were assessed.
• Fisher exact testing was used for statistical analysis.

Main Results:

• In the UltraTag RBC group, 2/15 nonheparinized samples clotted versus 0/15 heparinized samples.
• In the control group, 2/15 nonheparinized samples clotted versus 0/15 heparinized samples.
• Platelet clumping occurred in 3/15 nonheparinized and 3/15 heparinized UltraTag RBC samples, but in 15/15 nonheparinized and 10/15 heparinized control samples.

Conclusions:

• The UltraTag RBC kit demonstrated a higher likelihood of clot formation when heparin was omitted.
• Heparin use is advised to mitigate clotting risks when preparing UltraTag RBC kits.
• Standard use of heparin is recommended for all UltraTag RBC kit preparations in nuclear medicine.